Due to the fact that the action of Hsp inhibitors in overcoming chemoresistance is still an area of research, and their effectiveness may vary depending on the type and stage of cancer, taking up the topic in this field seems to be very important for cancer patients. Here, HSP90B2P is linked to cancer.